Ovarian Epithelial Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Epithelial Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-06-22Clinical Trial Results: Trial Evaluating Feasibility and Quality of Life of Second Look Laparoscopy With Hyperthermic Intraperitoneal Chemotherapy [Phase 2]
Phase 2 trial assessing feasibility and quality of life of second-look laparoscopy with hyperthermic intraperitoneal chemotherapy in ovarian…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Agnostic Therapy in Rare Solid Tumors [Phase 2]
A Phase 2 trial of an agnostic therapy for multiple rare solid tumors is currently recruiting. The study lists a broad set of tumor types ac…
-
CLINICAL_TRIALS trial_result · 2026-03-09Clinical Trial Update: Pembrolizumab/Placebo Plus Paclitaxel With or Without Bevacizumab for Platinum-resistant Recurrent Ovarian Cancer (MK-3475-B96/KEYNOTE-B96/ENGOT-ov65). [Phase 3]
Phase 3 trial assessing pembrolizumab with paclitaxel, with or without bevacizumab, for platinum-resistant recurrent ovarian cancer; results…
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: A Study to Learn if 27T51, a Mucin-16 (MUC16) Protein Targeting Immune Cell Therapy, Administered Alone or in Combination is Safe and How Well it Works for Adult Participants With Recurrent or Treatment Resistant Ovarian Cancers [Phase 1]
Phase 1 trial to evaluate the safety and preliminary effectiveness of 27T51, a MUC16-targeting immune cell therapy, in adults with recurrent…
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: Study to Evaluate the Preliminary Efficacy of SKB264 and the Effect of Clarithromycin on the PK of SKB264 in OC [Phase 2]
Phase 2 clinical trial evaluating preliminary efficacy of SKB264 and the effect of clarithromycin on SKB264 pharmacokinetics in ovarian epit…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-01-06Clinical Trial Update: A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers [Phase 1]
Phase 1 study assessing safety and early efficacy of KFA115 alone and in combination with pembrolizumab in select advanced cancers; the tria…
-
CLINICAL_TRIALS research · 2025-09-16Clinical Trial Update: Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer
Massachusetts General Hospital is sponsoring a study to develop a uterine lavage test for detecting ovarian cancer, and the trial is current…
-
CLINICAL_TRIALS research · 2025-09-09Clinical Trial Update: A Study of NX-1607 in Adults With Advanced Malignancies [Phase 1]
A Phase 1 study evaluating NX-1607 in adults with advanced malignancies is actively recruiting across multiple tumor types, including ovaria…
-
CLINICAL_TRIALS trial_result · 2024-05-14Clinical Trial Update: Study of XL102 as Single-Agent and Combination Therapy in Subjects With Solid Tumors (QUARTZ-101) [Phase 1]
Exelixis reports that the QUARTZ-101 Phase 1 trial of XL102 as a single agent and in combination therapy for solid tumors has been terminate…
-
CLINICAL_TRIALS trial_result · 2023-04-21Clinical Trial Update: Cyclophosphamide With or Without Celecoxib in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial evaluating cyclophosphamide with or without celecoxib in recurrent/persistent ovarian epithelial, fallopian tube, or primary p…
-
CLINICAL_TRIALS trial_result · 2022-07-06Clinical Trial Update: Evaluation of Ocoxin-Viusid® in Advanced or Metastatic Ovarian Epithelial Cancer [Phase 2]
Phase 2 clinical trial evaluating Ocoxin-Viusid in advanced or metastatic ovarian epithelial cancer has completed.
-
CLINICAL_TRIALS trial_result · 2022-06-24Clinical Trial Update: Paclitaxel and Ganetespib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 1, Phase 2]
Clinical trial update for paclitaxel and ganetespib in recurrent ovarian, fallopian tube, or primary peritoneal cancer; study terminated wit…
-
CLINICAL_TRIALS trial_result · 2022-05-04Clinical Trial Update: Phase II Study DCVAC/OvCa Added to First Line Carboplatin and Paclitaxel Newly Diagnosed Epithelial Ovarian Carcinoma [Phase 2]
Phase II study updating on adding DCVAC/OvCa to first-line carboplatin and paclitaxel for newly diagnosed epithelial ovarian cancer (Phase 2…
-
CLINICAL_TRIALS trial_result · 2022-04-25Clinical Trial Update: Autologous Dendritic Cells Loaded With Autologous Tumor Associated Antigens for Treatment of Advanced Epithelial Ovarian Carcinomas [Phase 2]
Phase 2 trial investigating autologous dendritic cells loaded with autologous tumor-associated antigens for advanced epithelial ovarian carc…
-
CLINICAL_TRIALS trial_result · 2021-08-10Clinical Trial Update: Paclitaxel i.v. Plus Cisplatin i.p for NACT in Patients With Advanced Ovarian Cancer [Phase 3]
A phase 3 trial evaluating paclitaxel intravenous plus cisplatin intraperitoneal for neoadjuvant chemotherapy in advanced ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2021-06-10Clinical Trial Update: Surgery or Chemotherapy in Recurrent Ovarian Cancer (SOC 1 Trial)? [Phase 3]
Phase 3 trial comparing surgery versus chemotherapy in recurrent ovarian cancer; status currently unknown.
-
CLINICAL_TRIALS trial_result · 2021-04-06Clinical Trial Update: Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial Cancer [Phase 1, Phase 2]
Phase 1/2 study of sacituzumab govitecan-hziy (IMMU-132) in adults with epithelial cancers; trial completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-01-29Clinical Trial Update: Circulating Tumor DNA Guiding (Olaparib) Lynparza® Treatment in Ovarian Cancer [Phase 2]
Phase 2 trial investigating circulating tumor DNA-guided olaparib (Lynparza) treatment in ovarian epithelial cancer.
-
CLINICAL_TRIALS trial_result · 2020-10-22Clinical Trial Update: PankoMab-GEX™ Versus Placebo as Maintenance Therapy in Advanced Ovarian Cancer [Phase 2]
A Phase 2 trial comparing PankoMab-GEX as maintenance therapy to placebo in advanced ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2020-06-05Clinical Trial Update: A Open Label Study of the Efficacy and Safety of PD0332991 a Selective Inhibitor of the Cyclin Dependent Kinases 4 and 6 in Patients With Recurrent Ovarian Cancer Demonstrating Rb-proficiency and Low p16 Expression [Phase 2]
Phase 2 open-label study evaluating PD0332991 (palbociclib) as a selective CDK4/6 inhibitor in recurrent ovarian cancer with RB-proficiency …
-
CLINICAL_TRIALS research · 2020-02-28Clinical Trial Update: Evaluation of Fluciclovine Uptake in Patients With Cervical, Ovarian Epithelial or Endometrial Cancers. [Phase 4]
Phase 4 trial evaluating fluciclovine uptake in cervical, endometrial, and ovarian epithelial cancers.
-
CLINICAL_TRIALS trial_result · 2019-11-19Clinical Trial Update: Bevacizumab and Trabectedin +/- Carboplatin in Advanced Ovarian Cancer [Phase 2]
Phase 2 trial assessing bevacizumab and trabectedin with or without carboplatin in recurrent ovarian epithelial cancer.
-
CLINICAL_TRIALS trial_result · 2019-11-01Clinical Trial Update: Cytoreductive Surgery and HIPEC in First or Secondary Platinum-resistant Recurrent Ovarian Epithelial Cancer [Phase 3]
Phase 3 trial update on cytoreductive surgery with HIPEC for first or second-line platinum-resistant recurrent ovarian epithelial cancer.
-
CLINICAL_TRIALS trial_result · 2019-07-23Clinical Trial Update: Vorinostat in Treating Patients With Recurrent or Persistent Ovarian Epithelial or Primary Peritoneal Cavity Cancer [Phase 2]
Phase 2 clinical trial update for vorinostat in recurrent or persistent ovarian epithelial cancer and primary peritoneal cancer.
-
CLINICAL_TRIALS trial_result · 2019-03-19Clinical Trial Update: Veliparib in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
A Phase 2 clinical trial evaluating veliparib in patients with persistent or recurrent epithelial ovarian, fallopian tube, or primary perito…